ACM
AZN icon

ADAR1 Capital Management’s AstraZeneca AZN Stock Holding History

ADAR1 Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,500
Closed -$827K – 314
2025
Q4 		$827K Buy
+4,500
New +$789K 0.06% 148
2024
Q4 		– Sell
-350
Closed -$54.5K – 227
2024
Q3 		$54.5K Buy
350
+300
+600% +$48.4K 0.01% 212
2024
Q2 		$7.8K Sell
50
-50
-50% -$7.52K ﹤0.01% 234
2024
Q1 		$13.6K Buy
+100
New +$13.2K ﹤0.01% 222

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $148B AUM

ADAR1 Capital Management's AZN Position: Q1 2026 in Review

ADAR1 Capital Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 4,500 shares — an estimated $827K sold.

ADAR1 Capital Management first reported a position in AZN in Q1 2024 and held it in 4 quarters. The position peaked at $827K in Q4 2025. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • ADAR1 Capital Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • ADAR1 Capital Management sold 4,500 AstraZeneca shares in Q1 2026, an estimated $827K.
  • ADAR1 Capital Management first reported a position in AstraZeneca in Q1 2024 and held it in 4 quarters.
  • ADAR1 Capital Management's AstraZeneca position peaked at $827K in Q4 2025.
  • 1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.